Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Department of Health Informatics, Rutgers School of Health Professions, Rutgers, The State University of New Jersey, Newark, United States; Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, United States
Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Ming Lei
Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Sarah K Bergren
Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Hanina Hibshoosh
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, United States
Department of Health Informatics, Rutgers School of Health Professions, Rutgers, The State University of New Jersey, Newark, United States; Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, United States
Department of Medicine, Columbia University Medical Center, New York, United States; Department of Genetics and Development, Columbia University Medical Center, New York, United States; Department of Urology, Columbia University Medical Center, New York, United States; Department of Systems Biology, Columbia University Medical Center, New York, United States; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, United States
Master regulatory genes of tissue specification play key roles in stem/progenitor cells and are often important in cancer. In the prostate, androgen receptor (AR) is a master regulator essential for development and tumorigenesis, but its specific functions in prostate stem/progenitor cells have not been elucidated. We have investigated AR function in CARNs (CAstration-Resistant Nkx3.1-expressing cells), a luminal stem/progenitor cell that functions in prostate regeneration. Using genetically--engineered mouse models and novel prostate epithelial cell lines, we find that progenitor properties of CARNs are largely unaffected by AR deletion, apart from decreased proliferation in vivo. Furthermore, AR loss suppresses tumor formation after deletion of the Pten tumor suppressor in CARNs; however, combined Pten deletion and activation of oncogenic Kras in AR-deleted CARNs result in tumors with focal neuroendocrine differentiation. Our findings show that AR modulates specific progenitor properties of CARNs, including their ability to serve as a cell of origin for prostate cancer.